MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20253152

January 14, 2025

Drug Information

瑞格列奈片

片剂

1mg

化学药品

January 14, 2025

Company Information

Applicant Company

通化市万通路66号

Manufacturing Company

通化市万通路66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath